Associate editor: V. Schini-KerthConditional gene targeting in the mouse nervous system: Insights into brain function and diseases
Introduction
One challenge of modern neurobiology is the identification of individual molecules that operate within neural circuits, regulate brain function and control synaptic plasticity. A unique approach to tackle the molecular basis of neuronal activity consists in manipulating the genome of higher organisms. In this context, the mouse represents an exceptional animal model which (i) is prone to targeted gene modifications, (ii) shares the complex genome and neuroanatomical organization of mammals and (iii) can be studied in paradigms which model the wide array of human neurological or psychiatric diseases.
The advent of gene targeting technology by homologous recombination (HR) in mouse has led to a first generation of so-called knockout animals (Capecchi, 1989). In these mutant mice, the gene of interest is inactivated following insertion of an antibiotic resistance gene within, or in place of, an essential exon (for detailed methods, see Dierich & Kieffer, 2004). Many genes expressed in the nervous system have been inactivated by HR. Phenotyping of these null mutant mice has provided invaluable information in the identification of key proteins involved in neural development and plasticity, as well as neurotransmission or drug activities in vivo. The conventional knockout (KO) technology, however, has limited utility in several situations. First, the gene of interest could be essential for development and survival, and the gene knockout lead to a lethal phenotype. Second, the targeted gene could be important for normal development and share functional redundancy with other genes. In this case the phenotype could be hardly detectable and would likely result from compensatory mechanisms that may be difficult to clarify. Third, some proteins are widely expressed both in the nervous system and peripheral tissues, and gene knockout throughout the body does not address their specific role in cerebral function. Additionally, and because of the high anatomic complexity of the nervous system, many neural proteins fulfill distinct functions depending on their site of expression within neurons and neural circuits. As a consequence, the complete deletion of a specific protein throughout the nervous system may prove ineffective towards understanding fine molecular processes in higher brain functions. Spatial and temporal control of the gene knockout, generally referred to as conditional gene knockout, was obviously the next step in the development of gene targeting technologies.
Among the many existing strategies that have been developed to modify the mouse genome (for extensive reviews, see Brusa, 1999, Lewandoski, 2001) the Cre-LoxP technology is the most popular approach to control targeted genetic inactivation in mice. The technique was first reported by Rajewski and colleagues to knockout the DNA polymerase beta gene specifically in T lymphocytes (Gu et al., 1994). Two years later, a similar approach was used in the field of neuroscience to address the role of N-methyl-d-aspartate (NMDA) receptor type 1 (NR1) subunit of the NMDA glutamate receptor in learning processes. In a pioneer set of studies, Tonegawa and coworkers circumvented the lethal phenotype of the NR1 null mutation by selective inactivation of the NR1 gene in the cornu ammonis field 1 of the hippocampus (CA1) after birth. Importantly, the data provided the first strong genetic evidence for a correlation between NMDA receptors, CA1 hippocampal long-term potentiation (LTP) and spatial learning (McHugh et al., 1996, Tsien et al., 1996a, Tsien et al., 1996b). The successful targeting of this important gene in hippocampus launched the development of cell type or regional specific gene knockout to study gene function in behaviors, neurological disorders or psychiatric diseases.
Because of the technical complexity of the approach itself, as well as the need to refine the spatial and temporal control of the genetic recombination, several previous review articles have largely addressed the methodological aspect of conditional gene targeting (see Morozov et al., 2003, Beglopoulos and Shen, 2004, Branda and Dymecki, 2004, Sorrell and Kolb, 2005). Although certainly not comprehensive, the present review will (i) summarize progress of conditional gene targeting in the entire brain, in selected brain areas, or in specific neuron populations using the Cre-LoxP system and (ii) overview behavioral alterations triggered by the conditional inactivation of more than 30 genes in the brain. Gene function during brain development is out of the scope of this review, and only the consequences of genetic inactivation in the adult brain are discussed.
Section snippets
A key tool: the Cre mouse
Cre recombinase is an enzyme isolated from bacteriophage P1, which specifically catalyzes recombination between two 34-bp loxP recognition sites located in genomic DNA. The reaction results in the irreversible excision of the DNA segment comprised between the 2 loxP sites. This property of the enzyme is used to target recombination events in the mouse genome, endogenously devoid of LoxP sites. Another site-specific recombinase system used is the Flp-frt system where Flp, or flippase, recombines
Conditional gene knockout and behavior
Here we summarize data from the phenotypic analysis of brain conditional mutant mice for a number of integrated responses, including sensory processes (Table 2), locomotion (Table 3), learning (Table 4), emotionality (Table 5), energy balance (Table 6), addictive behaviors and sleep. Altogether, the results provide a first hint on the implication of genes expressed throughout the nervous system, or in particular sites of the nervous system, in specific aspects of behavior.
For the study of
Conditional gene knockout and neurological diseases
Neurological diseases were investigated by conditional gene targeting approaches immediately after the technology was available. Many data have been reviewed earlier (Beglopoulos & Shen, 2004), and here we briefly summarize studies from 2000 onwards. In this field many genes under study have vital and broad functions; therefore, the conditional knockout approach is often a mandatory step because strong development abnormalities preclude full analysis of KO mutants. Importantly, some of these
Conclusion
Today, conditional targeted mutagenesis has become a rapidly moving field and phenotypic analyses of conditional mutant mice is accumulating. This review describes numerous genes whose function in the nervous system was examined by regionally and temporally controlled inactivation. Note that this survey summarizes studies reported until June 2006 only and may not be exhaustive. Based on the present availability of Cre lines, targeted areas mainly include the entire brain, although with mosaic
Acknowledgments
This work was supported by Centre de la Recherche National Scientifique, Institut National de la Santé Et de la Recherche Médicale, Université Louis Pasteur. We would like to thank the National Institute of Health (NIH-NIAAA AA13481, NIDA 016768) and the European Union (GENADDICT/FP6 005166) for their financial support. We are grateful to Jérôme Becker and Amynah Pradhan for careful reading of the manuscript.
References (174)
- et al.
Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice
J Biol Chem
(2006) - et al.
Deletion of presynaptic adenosine A1 receptors impairs the recovery of synaptic transmission after hypoxia
Neuroscience
(2005) - et al.
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis
Neuron
(2004) - et al.
Divergence of melanocortin pathways in the control of food intake and energy expenditure
Cell
(2005) - et al.
Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice
J Biol Chem
(2004) - et al.
Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice
Dev Cell
(2004) - et al.
Parallel “pain” pathways arise from subpopulations of primary afferent nociceptor
Neuron
(2005) Genetically modified mice in neuropharmacology
Pharmacol Res
(1999)- et al.
Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice
Biochem Biophys Res Commun
(2004) - et al.
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Neuron
(2006)
The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity
Cell Metab
Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour
C R Biol
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis
Neuron
A neurotrophic model for stress-related mood disorders
Biol Psychiatry
A role in learning for SRF: deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context
Neuron
Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces
Neuron
Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice
Biol Psychiatry
Specificity and efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice
Biochem Biophys Res Commun
Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model
Neuron
Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures
Dev Biol
Neuron-specific expression of Cre recombinase during the late phase of brain development
Neurosci Res
Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons
Neuron
Gene expression regulation following behavioral sensitization to cocaine in transgenic mice lacking the glucocorticoid receptor in the brain
Neuroscience
Developmental profile of kainate receptor subunit KA1 revealed by Cre expression in YAC transgenic mice
Brain Res
Inducible site-specific recombination in the brain
J Mol Biol
Purkinje cell-specific and inducible gene recombination system generated from C57BL/6 mouse ES cells
Biochem Biophys Res Commun
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome
Neuron
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA
Genomics
Molecular heterogeneity along the dorsal-ventral axis of the murine hippocampal CA1 field: a microarray analysis of gene expression
Neuroscience
Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells
Mol Cell Neurosci
NPY and Y receptors: lessons from transgenic and knockout models
Neuropeptides
Cre-mediated somatic site-specific recombination in mice
Nucleic Acids Res
Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal
Mol Psychiatry
Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons
J Neurosci
Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep
Proc Natl Acad Sci U S A
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation
Mol Cell Biol
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity
Cancer Res
Hypothalamic Y2 receptors regulate bone formation
J Clin Invest
Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system
Genesis
Cre recombinase expression in cerebellar Purkinje cells
Genesis
Conditional inactivation of the calbindin D-28k (Calb1) gene by Cre/loxP-mediated recombination
Genesis
Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination
J Neurosci
A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization
Neuropsychopharmacology
Neurotrophin-3 is required for proper cerebellar development
Nat Neurosci
Gene-targeting technologies for the study of neurological disorders
Neuromolecular Med
Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity
Proc Natl Acad Sci U S A
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Science
The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis
J Clin Invest
Genetic dissection of stress response pathways in vivo
Endocr Res
Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior
Proc Natl Acad Sci U S A
Cited by (116)
Phenotypic analysis with trans-recombination–based genetic mosaic models
2023, Journal of Biological ChemistryVitamin D and microRNAs
2023, Feldman and Pike's Vitamin D: Volume One: Biochemistry, Physiology and DiagnosticsAnimal models of developmental dyslexia: Where we are and what we are missing
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Conditional KO allows deletion in a tissue in a time specific manner. In contrast, gene knockdown, through genetic modification or by treatment with a reagent such as a short DNA or RNA oligonucleotide, can be complete or partial, resulting in expression defects by decreasing the transcript’s level or eliminating it altogether (Manis, 2007; Gavériaux-Ruff and Kieffer, 2007; Navabpour et al., 2020). The application of these techniques does not often produce the same results.
Genetic analysis of synaptogenesis
2020, Synapse Development and Maturation: Comprehensive Developmental Neuroscience